Podcast episode 111 (in German)

Turmeric – top of the list for herbal liver damage

October 19, 2026

Around 15.6 million adults in the US took turmeric within 30 days, more than the 14 million on a prescription cholesterol-lowering drug. This episode puts into context what the spice achieves for the knee, why it barely gets into the blood and what that has to do with the liver.

What it is about

Curcumin, the interesting component of turmeric root, acts like an anti-inflammatory in cell culture. In humans, the friendliest part should be said first: in knee osteoarthritis, turmeric relieves pain in the short term, on the order of a painkiller. Pure powder, however, barely reaches the blood, which is why manufacturers add piperine from black pepper or package it in micelles. It is precisely these tricks that stand out in the documented cases of liver damage. Along the way, the episode corrects its own database entry, which had attributed support for liver detoxification to the substance without a source. The conclusion is a distinction you can apply at the shelf: weeks have been studied, months have not.

Key points

A network meta-analysis of 23 studies with 2,175 patients found 1.63 points less pain versus placebo in knee osteoarthritis and 18.85 points on the total score of pain, stiffness and function.
In a head-to-head comparison in 367 people over 4 weeks, turmeric extract was not inferior to ibuprofen and caused fewer stomach complaints.
The most careful single trial, with 70 people over 12 weeks, found 9.1 millimeters less pain on a 100-millimeter line, confidence interval 17.8 to 0.4; effusion and cartilage remained unchanged.
In 24 volunteers, no curcumin was detectable in serum at 6 consecutive dose levels; only at the two highest were traces found in 2 people.
The US registry for liver injury lists 10 cases in 11 years, 6 of them since 2017; 5 of those affected were hospitalized, 1 died of acute liver failure.
Of the 10 affected, 7 carried the same tissue marker, which occurs in about 10 to 15 percent of the comparison population; on average 86 days passed until jaundice.
Of the products in the case series, 3 of 7 contained piperine, and for 2 products the German Federal Institute for Risk Assessment arrived at a good twice and almost three times the acceptable daily intake.

Where the data stop

How many of the 15.6 million develop liver damage, nobody knows. The survey asked 9,685 adults what they had taken in 30 days; it counts intake, not harm, and the authors themselves write that the sample is too small for harms that occur in fewer than 1 percent of those exposed. The stated frequency of 1 in 10,000 to 1 in 100,000 is an estimate, and the same paragraph says that it is not known. Neither “15 million are taking a liver toxin” nor “extremely rare isolated cases” is supported by the data.

The benefit has a limit too, and it is called duration: the osteoarthritis trials run for weeks, the harms come after months. For cancer prevention, anti-aging and liver support there is nothing comparable. The 7 for safety in the score is not praise; it is there because the harm is well documented. Anyone who takes such a product for months and becomes tired, gets dark urine or turns yellow has a question for a doctor.

Listen (in German)

Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music

Published on October 19, 2026.

The topic in the database

Relieves pain in knee osteoarthritis compared with placebo, not inferior to ibuprofen in a comparative trial. At the same time, the bioavailability tricks stand out in the case series on liver damage.Turmeric (curcumin)

All episodes in the app (German)

Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-06.